• Melanin, the pigment determining skin color, can absorb certain drugs, influencing their effectiveness based on skin tone.
• Preclinical research predominantly uses cell lines from people of European descent, potentially skewing drug development.
• Regulatory bodies are urged to implement guidelines promoting the use of diverse cellular models in drug testing.
• New legislation and FDA guidance aim to increase diversity in clinical trial participation, addressing historical underrepresentation.